Evidence map›Paper›PMID 42738287›Full record

ArticleCancers2026

Risk-Adapted Surveillance in Borderline Ovarian Tumours (BOTs): The "Barts" Evidence-Based Framework.

Sofia Lekka, Shaun Haran, Nadia Amel Seksaf, Iteeka Arora, Arjun Jeyarajah, Saurabh Phadnis, Alexandra Lawrence, Elly Brockbank, Ranjit Manchanda, Michail Sideris

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sofia LekkaDepartment of Gynaecological Oncology, Royal London Hospital, Barts Health NHS Trust, London E1 1FR, UK.
Shaun HaranDepartment of Gynaecological Oncology, Royal London Hospital, Barts Health NHS Trust, London E1 1FR, UK.
Nadia Amel SeksafDepartment of Gynaecological Oncology, Royal London Hospital, Barts Health NHS Trust, London E1 1FR, UK.ORCID 0009-0007-6615-2807
Iteeka AroraDepartment of Gynaecological Oncology, Royal London Hospital, Barts Health NHS Trust, London E1 1FR, UK.
Arjun JeyarajahDepartment of Gynaecological Oncology, Royal London Hospital, Barts Health NHS Trust, London E1 1FR, UK.
Saurabh PhadnisDepartment of Gynaecological Oncology, Royal London Hospital, Barts Health NHS Trust, London E1 1FR, UK.
Alexandra LawrenceDepartment of Gynaecological Oncology, Royal London Hospital, Barts Health NHS Trust, London E1 1FR, UK.
Elly BrockbankDepartment of Gynaecological Oncology, Royal London Hospital, Barts Health NHS Trust, London E1 1FR, UK.
Ranjit ManchandaDepartment of Gynaecological Oncology, Royal London Hospital, Barts Health NHS Trust, London E1 1FR, UK.ORCID 0000-0003-3381-5057
Michail SiderisDepartment of Gynaecological Oncology, Royal London Hospital, Barts Health NHS Trust, London E1 1FR, UK.ORCID 0000-0002-4199-6700

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

borderline ovarian tumourmalignant transformationpatient-initiated follow-uprecurrence patternsrisk-adapted surveillance

Identifiers

PMID42738287
PMCPMC13564584

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.